Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Experts Recommend Approval of Sinovac’s H1N1 Flu Vaccine

publication date: Aug 31, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech (北京科兴生物制品有限公司) continued its barrage of H1N1 flu vaccine news by announcing that its product passed an experts’ evaluation organized by the SFDA. After spending August 30 and 31 looking at data from the vaccine’s recent clinical trial, the experts recommended approval of the product. The data and the evaluation will be submitted to the SFDA, and Sinovac expects to be given a production license later this week. Sinovac's shares soared following the announcement. More details...

Stock Symbol: (NYSE Amex: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners